首页> 外文期刊>International journal of infectious diseases : >Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China
【24h】

Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China

机译:在中国上海水痘暴发期间水痘疫苗作为暴露后预防的有效性

获取原文
           

摘要

Objectives Varicella vaccine (VarV) is recommended as effective post-exposure prophylaxis (PEP) within 3–5 days to control outbreaks. However, the effectiveness of PEP at >5 days after exposure and the administration of a second dose to those with a history of one dose prior to exposure have not been fully examined. This study evaluated the vaccine effectiveness (VE) of PEP in preventing disease during a varicella outbreak in Shanghai, China in 2013. Methods Self-administered questionnaires were used to obtain the students’ varicella history, vaccination status, and willingness to receive PEP. One dose of VarV was provided free of charge to eligible students. The VE of PEP was calculated as [1 ? relative risk (RR)] × 100%. Analyses were restricted to grade 8 students, as no students from the other grades or teachers developed varicella during the outbreak. Results Twenty-seven varicella cases were identified, 16 (59%) of which were infected after the PEP campaign. Sixty-five students received one dose of VarV on day 13 or 19 after the index case. Attack rates were 28% (9/32), 16% (15/94), 0% (0/10), and 6% (3/55) among unvaccinated, one-dose Pre-PEP, first dose as PEP, and second dose as PEP recipients, respectively. Cases among second dose as PEP recipients tended to have less fever compared with unvaccinated or one-dose Pre-PEP recipients. Compared with unvaccinated students, the VE of first dose as PEP recipients was 100% and of the second dose as PEP recipients was 60% (95% confidence interval ?72% to 91%). Conclusions Post-exposure vaccination should be given as soon as possible after exposure. Nevertheless, vaccination is still recommended even at more than 5 days post-exposure to control varicella outbreaks.
机译:目的建议使用水痘疫苗(VarV)作为3至5天内的有效暴露后预防(PEP),以控制暴发。但是,尚未充分检查PEP在暴露后> 5天的有效性以及对有暴露前一剂病史的患者进行第二剂给药的有效性。这项研究评估了2013年中国上海水痘爆发期间PEP预防疾病的疫苗效力(VE)。方法使用自填式问卷调查来获取学生的水痘病史,疫苗接种状况以及接受PEP的意愿。向符合条件的学生免费提供一剂VarV。 PEP的VE计算为[1?相对风险(RR)]×100%。分析仅限于8年级的学生,因为在爆发期间没有其他年级的学生或老师出现水痘。结果确认了27例水痘病例,其中PEP运动后感染了16例(59%)。在索引病例后的第13天或第19天,有65名学生接受了一剂VarV。在未接种的一剂PEP疫苗中,未接种的PEP疫苗的发作率分别为28%(9/32),16%(15/94),0%(0/10)和6%(3/55),和第二剂分别为PEP接受者。与未接种疫苗或单剂量Pre-PEP接受者相比,第二次接受PEP接受者的发烧倾向较少。与未接种疫苗的学生相比,PEP接受者第一剂的VE为100%,PEP接受者第二剂的VE为60%(95%置信区间为72%至91%)。结论暴露后应尽快进行暴露后疫苗接种。尽管如此,仍建议即使在暴露后5天以上也要接​​种疫苗,以控制水痘的爆发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号